Templeton Emerging Markets Fund
EMF · NYSE
8/31/2025 | 2/28/2025 | 8/31/2024 | 2/29/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.09 | 0.01 | -0.22 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 5.57 | 0.00 | 9.22 | 25.60 |
| Quality | ||||
| ROIC | 840.56% | 3.57% | 8.84% | 0.58% |
| Gross Margin | 86.27% | 100.00% | 89.98% | 83.15% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | -7.83% | -4.51% | -1.79% | -4.82% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 0.14 | 0.00 | 0.23 | 0.70 |
| Interest Coverage | 0.00 | 59.28 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 17.64 | 85.04 | -2.10 | -21.89 |